Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Themes Investment Partners

Founders Frank Yu

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$19M
Portfolio companies 3
Lead investments 1
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutic Devices
  • Genetics
Summary

The company was established in North America in United States. The main department of described VC is located in the New York.

This organization was formed by Frank Yu.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2013. The real fund results show that this VC is 13 percentage points more often commits exit comparing to other companies.

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular fund investment industries, there are Biopharma, Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Sonendo, Apexigen, Lonestar Heart. The fund has specific favorite in a number of founders of portfolio startups.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Themes Investment Partners, startups are often financed by OrbiMed, Neomed Management, Fjord Ventures. The meaningful sponsors for the fund in investment in the same round are WSR Capital, Sycamore Ventures, OrbiMed. In the next rounds fund is usually obtained by OrbiMed, Neomed Management, Meritech Capital Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Themes Investment Partners:
Typical Co-investors
Themes Investment Partners is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Themes Investment Partners:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Batterson Venture Capital Chicago, Illinois, United States
Dough Chicago, Illinois, United States
Guoxing Fund China, Guangdong, Shenzhen
Overton Venture Capital New York, New York, United States
Sanshengshi Chuangtou China, Hangzhou, Zhejiang
Societe National de Credit et d'Investissement -
Sunstone Management California, Long Beach, United States
Techstars Allied Space Accelerator -
Vietnam Innovative Startup Accelerator Chicago, Illinois, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Apexigen

Biopharma
Biotechnology
Health Care
Pharmaceutical
$20M06 Aug 2013 California, United States

Sonendo

Biotechnology
Health Care
Medical
$18M04 Jun 2013 California, United States

Lonestar Heart

Biotechnology
Genetics
Medical Device
Therapeutic Devices
Therapeutics
$20M10 Oct 2012 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Themes Investment Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 19M
Peak activity year 2013
Lead investments 1
Group Appearance index 0.67

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Apexigen

Biopharma
Biotechnology
Health Care
Pharmaceutical
$20M06 Aug 2013 California, United States

Sonendo

Biotechnology
Health Care
Medical
$18M04 Jun 2013 California, United States

Lonestar Heart

Biotechnology
Genetics
Medical Device
Therapeutic Devices
Therapeutics
$20M10 Oct 2012 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: